Treatment of posttransplantation diabetes mellitus with anti-CD20 monoclonal antibodies

被引：0
|
作者：
Vandenbosch, K [1 ]
Champagne, MA [1 ]
Gonthier, M [1 ]
Moghrabi, A [1 ]
Vachon, MF [1 ]
Duval, M [1 ]
机构：
[1] Hop St Justine, Montreal, PQ H3T 1C5, Canada
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2005年 / 11卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2004.12.192
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
192
引用
收藏
页码：64 / 64
页数：1
相关论文
共 50 条
  • [21] Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk - No
    Tallantyre, Emma C.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (08) : 1175 - 1177
  • [22] New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies
    Robak, Tadeusz
    Robak, Ewa
    BIODRUGS, 2011, 25 (01) : 13 - 25
  • [23] New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies
    Tadeusz Robak
    Ewa Robak
    BioDrugs, 2011, 25 : 13 - 25
  • [24] Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment
    Silvia R. Delgado
    Simon Faissner
    Ralf A. Linker
    Kottil Rammohan
    Journal of Neurology, 2024, 271 : 1515 - 1535
  • [25] Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus
    Arin, MJ
    Engert, A
    Krieg, T
    Hunzelmann, N
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (03) : 620 - 625
  • [26] Idiopathic systemic vasculitis (IVS) remission after treatment with anti-CD20 monoclonal antibodies
    Roccatello, D.
    Rossi, D.
    Baldovino, S.
    Alpa, M.
    Naretto, C.
    Brosio, P.
    Napoli, F.
    La Grotta, R.
    Cavallo, R.
    Giachino, O.
    Sena, L. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 382 - 383
  • [27] Place of monoclonal antibodies (anti-CD52, anti-CD20) in chronic lymphocytic leukemia
    Divine, Marine
    HEMATOLOGIE, 2006, 12 : 35 - 38
  • [28] All anti-CD20 monoclonal antibodies have similar efficacy and risks: No
    Sellebjerg, Finn
    Christensen, Jeppe Romme
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (12) : 1845 - 1846
  • [29] The role of antigenic modulation in controlling the efficacy of anti-CD20 monoclonal antibodies
    Beers, S. A.
    Chan, C. H. T.
    James, S.
    French, R. R.
    Attfield, K. E.
    Brennand, C. M.
    Ahuja, A.
    Shlomchik, M.
    Cragg, M. S.
    Glennie, M. J.
    IMMUNOLOGY, 2008, 125 : 48 - 49
  • [30] Monoclonal anti-CD20 antibodies: Mechanisms of action and monitoring of biological effects
    Renaudineau, Yves
    Devauchelle-Pensec, Valerie
    Hanrotel, Catherine
    Pers, Jacques-Olivier
    Saraux, Alain
    Youinou, Pierre
    JOINT BONE SPINE, 2009, 76 (05) : 458 - 463
12345